UK Campaign to Stop Genetically Modified Human Embryos
By Marcy Darnovsky,
Genetic Crossroads
| 02. 28. 2007
The UK-based Human Genetics Alert (HGA) has launched a campaign to prevent Britain from becoming the first country in the world to sanction the production of genetically modified human embryos. As reported in the January issue of Genetic Crossroads, a bill set to be introduced would allow British scientists to begin developing technologies that could be used in efforts toward inheritable genetic modification.
Speaking at an HGA press conference, Dr. Richard Nicholson, editor of the Bulletin of Medical Ethics, said, "Every country that has legislated on this subject has banned it. Thus the British Government's decision breaks ranks with the international community, and may lead to the perception that Britain is a haven for irresponsible and profit-driven scientists."
The proposed law maintains the UK's existing ban on creating genetically modified children. But although the white paper supporting the proposed legislation says that genetically altering eggs, sperm and embryos "should not be permitted for reproductive purposes," it adds that this is only "for the foreseeable future, and until such time as safety and efficacy are assured."
HGA Director Dr...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...